Alpha-defensins as anthrax immunotherapeutis
AssigneeMax-Planck-Gesellschaft zur Föderung der Wissenschaften e.V.
InventorsChun Kim, Stefan Kaufmann, Nadesan Gajendran
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an alpha-defensin in the manufacture of a medicament for the treatment, amelioration or prevention of a disease caused by Bacillus anthracis (B anthracis) infection. Furthermore, methods for the treatment of an B. anthracis infection as well as methods of protection against a B. anthracis infection, e.g. a vaccination are described.
Claims14
1-4. (canceled)
A method of treating, preventing or ameliorating a disease caused by B. anthracis comprising administering to a subject in need of such a treatment, prevention or amelioration an alpha-defensin.
Dependencies are inferred from the claim text.